Provider fact sheet · dataset v2026.08.14-4 · last touched —
Skinny Rx: GLP-1 programs, prices, and verification status (2026)
Skinny Rx is a unverified entry in our universe. Appears in GLP-1 Watchdog's rankings ('best oral option', 8.9) with multi-format offerings including orals — which places it directly in the unproven-format conversation our tablet analysis covers.
Programs and pricing, in plain sentences
program — status: unverified.
Every figure above carries its status — operator claims come from the provider, reported from third parties we cite, verified only after our own checkout walk. Machine-readable version: providers.json.
Verification status and open items
Current status: unverified, last touched —. Open verification items: dispensing pharmacy identity, state coverage map, cancellation terms. Source on file: universe scan. Corrections land within 48 hours via the public log — if your checkout contradicts this page, that report changes the dataset.
How Skinny Rx fits the market
Appears in GLP-1 Watchdog's rankings ('best oral option', 8.9) with multi-format offerings including orals — which places it directly in the unproven-format conversation our tablet analysis covers. Reported ~$199; unverified beyond aggregator claims. Where it lands overall: the price ladder, the category winners, and the program finder all compute from the same dataset this page renders.
Advertising disclosure: outbound provider links may be commission-bearing; our partner relationship with NexLife is disclosed on the ownership page and never alters statuses or rankings.